Mar 10, 2021 / 09:45PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Good afternoon. My name is Gena Wang. I'm SMID Cap biotech analyst at Barclays. Welcome to our second virtual Global Healthcare Conference. First, I wish everyone stay healthy. And I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual health care conference possible.
And with that, I would like to introduce, our next presenting company is Ultragenyx. With us today, we have Emil Kakkis, Chief Executive Officer. Also, we have Mardi Dier, Chief Financial Officer, with us. I will hand over to you, Emil, for a brief overview of the company.
Emil D. Kakkis - Ultragenyx Pharmaceutical Inc. - President, CEO & Director
Thanks, Gena, and happy to be here with you today. Ultragenyx has had a great 2020, even though it was a terrible 2020 overall for the world. But in our 10th year, we managed to now have 4 approvals, 2 of them last year and earned a moat of increasing revenue generation with $271
Ultragenyx Pharmaceutical Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers